当前位置：
X-MOL 学术
›
BMC Cancer
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction to: A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients
BMC Cancer ( IF 3.8 ) Pub Date : 2020-03-12 , DOI: 10.1186/s12885-020-6691-0 Chaoyang Sun , Ensong Guo , Bo Zhou , Wanying Shan , Jia Huang , Danhui Weng , Peng Wu , Changyu Wang , Shixuan Wang , Wei Zhang , Qinglei Gao , Xiaoyan Xu , Beibei Wang , Junbo Hu , Ding Ma , Gang Chen
BMC Cancer ( IF 3.8 ) Pub Date : 2020-03-12 , DOI: 10.1186/s12885-020-6691-0 Chaoyang Sun , Ensong Guo , Bo Zhou , Wanying Shan , Jia Huang , Danhui Weng , Peng Wu , Changyu Wang , Shixuan Wang , Wei Zhang , Qinglei Gao , Xiaoyan Xu , Beibei Wang , Junbo Hu , Ding Ma , Gang Chen
Following publication of the original article [1], the authors reported an error in Fig. 1f.
中文翻译：
更正为：活性氧物种评分系统预测卵巢癌患者的顺铂敏感性和预后
在发表原始文章[1]之后，作者报告了图1f中的错误。
更新日期：2020-03-12
中文翻译：
更正为：活性氧物种评分系统预测卵巢癌患者的顺铂敏感性和预后
在发表原始文章[1]之后，作者报告了图1f中的错误。
京公网安备 11010802027423号